← Evidence map

ArticleAmerican journal of translational research2016

MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.

Yi Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.

50 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27508026